The key role of microvascular structure assessment in treated hypertensive patients

Journal of Hypertension

Volumn 30, Issue 4, 2012, Pages 688-690

  Savoia, Carmine ^a   Grassi, Guido ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SAN GERARDO HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN ANTAGONIST; CALCIUM CHANNEL BLOCKING AGENT;

ARTERIAL STIFFNESS; ARTERIAL WALL THICKNESS; ARTERIOLE; ARTERY; ATHEROSCLEROSIS; BLOOD VESSEL DIAMETER; BLOOD VESSEL INJURY; BLOOD VESSEL PARAMETERS; CHRONIC DISEASE; CORONARY ARTERY BLOOD FLOW; ENDOTHELIAL DYSFUNCTION; ESSENTIAL HYPERTENSION; HEART OUTPUT; HEART RATE; HUMAN; HYPERTENSION; MICROVASCULAR STRUCTURE; MORPHOLOGY; NOTE; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; SIGNAL TRANSDUCTION; VASCULAR RESISTANCE; WALL STRESS;

EID: 84858630832     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0b013e328351c174     Document Type: Note

References (30)

1. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al. 2007 guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007; 25:1105-1187. (Pubitemid 46924065)
2. Schiffrin EL. Remodeling of resistance arteries inessential hypertension and effects of antihypertensive treatment. Am J Hypertens 2004; 17:1192-1200. (Pubitemid 40029420)
3. Schiffrin EL, Touyz RM. From bedside to bench to bedside: role of renin angiotensin aldosterone system in remodeling of resistance arteries in hypertension. Am J Physiol Heart Circ Physiol 2004; 287:H435-H446. (Pubitemid 38960790)
4. Mulvany MJ, Baumbach GL, Aalkjaer C, Heagerty AM, Korsgaard N, Schiffrin EL, Heistad DD. Vascular remodeling [letter]. Hypertension 1996; 28:505-506.
5. van der Akker J, Schoorl MJ, Bakker ENTP, Vanbavel E. Small artery remodeling: current concepts and questions. J Vasc Res 2010; 47:183-202.
6. Sonoyama K, Greenstein A, Price A, Khavandi K, Heagerty T. Vascular remodeling: implications for small artery function and target organ damage. Ther Adv Cardiovasc Dis 2007; 1:129-137.
7. Rizzoni D, Porteri E, Guelfi D, Muiesan M, Valentini U, Cimino A, et al. Structural alteration in subcutaneous small arteries of normotensive and hypertensive patients with noninsulin-dependent diabetes mellitus. Circulation 2001; 103:1238-1244. (Pubitemid 32221346)
8. Endemann DH, Pu Q, De Ciuceis C, Savoia C, Virdis A, Neves MF, et al. Persistent remodeling of resistance arteries in type 2 diabetic patients on antihypertensive treatment. Hypertension 2004; 43:399-404. (Pubitemid 38174146)
9. Rizzoni D, Porteri E, Guelfi D, Piccoli A, Castellano M, Pasini GM, et al. Cellular hypertrophy in subcutaneous small arteries of patients with renovascular hypertension. Hypertension 2000; 25:931-935. (Pubitemid 30303953)
10. Mulvany MJ, Aalkjaer C. Structure and function of small arteries. Physiol Rev 1990; 70:921-971.
11. Schiffrin EL, Hayoz D. How to assess vascular remodelling in small and medium-sized muscular arteries in humans. J Hypertens 1997; 15:571-584. (Pubitemid 27246532)
12. Park JB, Schiffrin EL. Small artery remodeling is the most prevalent (earliest?) form of target organ damage in mild essential hypertension. J Hypertens 2001; 19:921-930. (Pubitemid 32436957)
13. Rizzoni D, Porteri E, Boari G, De Ciuceis C, Sleiman ML, Muiesan M, et al. Prognostic significance of small artery structure in hypertension. Circulation 2003; 108:2230-2235. (Pubitemid 37363040)
14. Mancia G, Laurent S, Agabiti-Rosei E, Ambrosioni E, Burnier M, Caulfield MJ, et al., European Society of Hypertension. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J Hypertens 2009; 27:2121-2158.
15. Sivertsson R, Hansson L. Effects of blood pressure reduction on the structural vascular abnormality in skin and muscle vascular beds in human essential hypertension. Clin Sci Mol Med 1976; 51:77S-79S.
16. Sivertsson R. The hemodynamic importance of structural vascular changes in essential hypertension. Acta Physiol Scand 1970; 343:1-56.
17. Folkow B, Grimby G, Thulesius O. Adaptive structural changes of the vascular walls in hypertension and their relation to the control of the peripheral resistance. Acta Physiol Scand 1957; 44:255-272.
18. Conway J. A vascular abnormality in hypertension: a study of blood flow in the forearm. Circulation 1963; 27:520-529.
19. Motz W, Vogt S, Scheler B, Schwartzkopff B, Strauer BE. Coronary circulation in arterial hypertension. J Cardiovasc Pharmacol 1991; 17:S35-S39.
20. Williams SA, Tooke JW. Noninvasive estimation of increased structurally-based resistance to blood flow in the skin of subjects with essential hypertension. Int J Microcirc Clin Exp 1992; 11:109-116.
21. Rosei EA, Rizzoni D, Castellano M, Porteri E, Zulli R, Muiesan ML, et al. Media: lumen ratio in human small resistance arteries is related to forearm minimal vascular resistance. J Hypertens 1995; 13:341-347.
22. Eftekhari A, Mathiassen ON, Buus NH, Gotzsche O, Mulvany MJ, Christensen KL. Changes in blood pressure and systemic vascular resistance do not predict microvascular structure during treatment of mild essential hypertension. J Hypertens 2012; 30:794-801.
23. Veerman DP, Imholz BP, Wieling W, Wesseling KH, van Montfrans GA. Circadian profile of systemic hemodynamics. Hypertension 1995; 26:55-59.
24. Mathiassen ON, Buus NH, Larsen ML, Mulvany MJ, Christensen KL. Small artery structure adapts to vasodilatation rather than to blood pressure during antihypertensive treatment. J Hypertens 2007; 25:1027-1034. (Pubitemid 46573122)
25. Thybo NK, Stephens N, Cooper A, Aalkjaer C, Heagerty AM, Mulvany MJ. Effect of antihypertensive treatment on small arteries of patients with previously untreated essential hypertension. Hypertension 1995; 25:474-481.
26. Schiffrin EL, Pu Q, Park JB. Effect of amlodipine compared to atenolol on small arteries of previously untreated essential hypertensive patients. Am J Hypertens 2002; 15:105-110. (Pubitemid 34161083)
27. Savoia C, Touyz R, Amiri F, Schiffrin EL. Selective mineralocorticoid receptor blocker eplerenone reduces resistance artery stiffness in hypertensive patients. Hypertension 2008; 51:432-439. (Pubitemid 351156429)
28. Savoia C, Touyz RM, Endemann DH, Pu Q, Ko EA, De Ciuceis C, Schiffrin EL. Angiotensin receptor blocker added to previous antihypertensive agents on arteries of diabetic hypertensive patients. Hypertension 2006; 48:271-277. (Pubitemid 44309823)
29. Rizzoni D, Palombo C, Porteri E, Muiesan ML, Kozakova M, La CG, et al. Relationships between coronary flow vasodilator capacity and small artery remodelling in hypertensive patients. J Hypertens 2003; 21:625-631. (Pubitemid 36418976)
30. Olsen MH, Wachtell K, Meyer C, Hove JD, Palmieri V, Dige-Petersen H, et al. Association between vascular dysfunction and reduced myocardial flow reserve in patients with hypertension: a LIFE substudy. J Hum Hypertens 2004; 18:445-452. (Pubitemid 38787040)